
Growth equity · Growth stage · Est. 2013
HighCape Capital
HighCape Capital is a growth equity fund focused on life sciences companies, run by seasoned industry executives. It invests in connected health, medical devices and tools, and biotechnology.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is HighCape Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds HighCape Capital joined, from press and the firm’s own posts.
Every round HighCape Capital joined
Round sizes, HighCape Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company HighCape Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet HighCape Capital
Events where HighCape Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
HighCape Capital is based in Westport, United States.
In 2013.
11 fund vehicles are on public registers (SEC adviser filings), including HIGHCAPE PARTNERS QP II, LP, HIGHCAPE SPECIAL OPPORTUNITIES 4-A, LLC and HIGHCAPE SPECIAL OPPORTUNITIES 4-B, LLC.
Stages: Growth. Sectors: Life sciences. From the firm’s own website.
The firm helps innovative life sciences companies mature from early business stages into thriving organizations. A team of experienced operators and investors works hands-on with management on commercial and operational strategy, adding talent where needed. From the firm’s own website.
HighCape Capital lists 9 portfolio companies on its website, including Elutia, Quantum-Si, Wellinks, Cybrexa and Alphina Therapeutics.
Firms whose websites list some of the same companies include Canaan, EW Healthcare Partners and Foresite Capital.
Know before HighCape Capital’s next round is announced.
PRO tracks HighCape Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.